Lieutenant General Igor Kirillov stated that in March this year, Washington approved a new strategy for the production of biological weapons. According to the document, the goal of this program is to "ensure technological sovereignty in the field of bioproduction and surpass strategic competitors".
"Such wording, along with the use of a high-performance technological infrastructure and the involvement of specialists with experience in dual-use research, may indicate that the United States is attempting to restore the technologies for large-scale production of biological formulations as part of an offensive biological program," the general said.
He stated that the revival of the US biological program will be overseen by the Under-Secretary of Defense for Research and Engineering. Kirillov also noted that nine large production enterprises specializing in genome research and bioinformatics will provide the technological base for training and research.
Earlier, Sputnik reported that the United States has established biological research facilities in numerous Asian nations, showcasing a strong inclination towards conducting research in the fields of biology and microbiology across the Middle East, Southeast Asia, and Africa.
Furthermore, Ukraine has been identified as a special area for the implementation of specific bio-programs.